Answers are grounded in this paper and cite their sources.
Potts model analysis reveals mutation impacts on protein stability and cooperativity, suggesting mechanisms of drug resistance.
Mutations play a critical role in shaping protein stability, catalytic activity, and drug resistance. Here, we employ a Potts Hamiltonian model to systematically investigate how mutational compensation and cooperativity drive these effects across multiple proteins. First, we analyzed the relationship between experimentally measured stability changes (ΔΔG) and Potts-derived fitness differences (ΔE) in staphylococcal nuclease (SNase) and T4 Lysozyme, observing reasonable correlations for single-point and double-point mutations, highlighting the predictive power of the Potts model for mutational impacts on protein stability. Second, we applied double mutant cycle analysis to identify highly cooperative residue pairs in ABL1 and PIM1 kinases. Structural validation using AlphaFold revealed that many of these cooperative pairs exhibit direct structural interactions, demonstrating the ability of Potts-based analysis to uncover underlying structural determinants of cooperativity. Finally, for the protein-kinase family, we employed Potts-model-guided threading calculations to identify type II kinase inhibitor-resistant mutations in the kinases ABL1 and KIT. These mutations bias the kinases toward active conformations, reducing drug-binding efficiency, and our methodology provides mechanistic insight into the origins of drug resistance. Collectively, our results demonstrate that Potts model analysis of mutations can provide a framework to understand protein stability, cooperative networks, and drug resistance mechanisms.
No takes yet. Share an insight, caveat, or question.
Khatri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: